OPLUSOF Trademark

Trademark Overview


On Monday, June 9, 2014, a trademark application was filed for OPLUSOF with the United States Patent and Trademark Office. The USPTO has given the OPLUSOF trademark a serial number of 86303661. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 14, 2022. This trademark is owned by Glaxo Group Limited. The OPLUSOF trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
oplusof

General Information


Serial Number86303661
Word MarkOPLUSOF
Filing DateMonday, June 9, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 14, 2022
Registration Number4767264
Registration DateTuesday, July 7, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 14, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, January 14, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, July 7, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 7, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2015PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 16, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 11, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 11, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 11, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 11, 2015ASSIGNED TO LIE
Monday, March 2, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, September 18, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, September 18, 2014LETTER OF SUSPENSION E-MAILED
Thursday, September 18, 2014SUSPENSION LETTER WRITTEN
Thursday, September 18, 2014ASSIGNED TO EXAMINER
Thursday, June 19, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 12, 2014NEW APPLICATION ENTERED IN TRAM